Cargando…

Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth

In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Luciani, Lorenzo, Galassi, Rossana, Wang, Junbiao, Marchini, Cristina, Cogo, Alessia, Di Paolo, Maria Luisa, Dalla Via, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325969/
https://www.ncbi.nlm.nih.gov/pubmed/35910727
http://dx.doi.org/10.3389/fchem.2022.924584
_version_ 1784757172735836160
author Luciani, Lorenzo
Galassi, Rossana
Wang, Junbiao
Marchini, Cristina
Cogo, Alessia
Di Paolo, Maria Luisa
Dalla Via, Lisa
author_facet Luciani, Lorenzo
Galassi, Rossana
Wang, Junbiao
Marchini, Cristina
Cogo, Alessia
Di Paolo, Maria Luisa
Dalla Via, Lisa
author_sort Luciani, Lorenzo
collection PubMed
description In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds exhibiting remarkable cytotoxic activities. Functional groups in the aryl moieties modulate the activity reinforcing or eliminating it. Previous works have highlighted that the presence of hydrophilic groups in the phosphane ligands, such as COOH or OH, hampers the anticancer activity of gold azolate/PPh(3) compounds. To increase the polarity of the triarylphosphane ligand without affecting the activity, we considered the preparation of esters starting from the 4-diphenylphosphane-benzoic acid. The resulting phosphanes are poorer donators than the PPh(3), leading to poly-phosphane M(I) compounds, and they exhibit intense emissive properties. A homologous series of L(3)MX-type compounds (where M = Au and X = Cl, M = Cu and X = BF(4), and M = Ag and X = PF(6)) were obtained with the 4-methoxy-diphenylphosphane benzoate. The homologous metal compounds have been characterized by analytical and spectroscopic methods and, remarkably, their formation was associated with high frequencies of (31)P NMR chemical shift variations (5–35 ppm in CDCl(3)). The new complexes and the ligand were evaluated on sensitive and cisplatin-resistant human tumor cell lines. The ligand is ineffective on cells while the complexes exert a notable antiproliferative effect. The homologous series of the L(3)MX complexes were able to significantly reduce the cell viability of human triple-negative breast cancer cells (MDA-MB-231), representing the most aggressive subtype of breast cancer, and of ovarian carcinoma (A2780). Among these coinage metal compounds, L(3)AgPF(6) results the most interesting, showing the lowest GI(50) values in all cell lines. Interestingly, this silver complex is more cytotoxic than cisplatin, taken as reference drug. The investigation of the mechanism of action of L(3)AgPF(6) in A2780 cells highlighted the induction of the apoptotic pathway, the depolarization of the mitochondrial inner membrane, and a significant accumulation in cells.
format Online
Article
Text
id pubmed-9325969
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93259692022-07-28 Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth Luciani, Lorenzo Galassi, Rossana Wang, Junbiao Marchini, Cristina Cogo, Alessia Di Paolo, Maria Luisa Dalla Via, Lisa Front Chem Chemistry In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds exhibiting remarkable cytotoxic activities. Functional groups in the aryl moieties modulate the activity reinforcing or eliminating it. Previous works have highlighted that the presence of hydrophilic groups in the phosphane ligands, such as COOH or OH, hampers the anticancer activity of gold azolate/PPh(3) compounds. To increase the polarity of the triarylphosphane ligand without affecting the activity, we considered the preparation of esters starting from the 4-diphenylphosphane-benzoic acid. The resulting phosphanes are poorer donators than the PPh(3), leading to poly-phosphane M(I) compounds, and they exhibit intense emissive properties. A homologous series of L(3)MX-type compounds (where M = Au and X = Cl, M = Cu and X = BF(4), and M = Ag and X = PF(6)) were obtained with the 4-methoxy-diphenylphosphane benzoate. The homologous metal compounds have been characterized by analytical and spectroscopic methods and, remarkably, their formation was associated with high frequencies of (31)P NMR chemical shift variations (5–35 ppm in CDCl(3)). The new complexes and the ligand were evaluated on sensitive and cisplatin-resistant human tumor cell lines. The ligand is ineffective on cells while the complexes exert a notable antiproliferative effect. The homologous series of the L(3)MX complexes were able to significantly reduce the cell viability of human triple-negative breast cancer cells (MDA-MB-231), representing the most aggressive subtype of breast cancer, and of ovarian carcinoma (A2780). Among these coinage metal compounds, L(3)AgPF(6) results the most interesting, showing the lowest GI(50) values in all cell lines. Interestingly, this silver complex is more cytotoxic than cisplatin, taken as reference drug. The investigation of the mechanism of action of L(3)AgPF(6) in A2780 cells highlighted the induction of the apoptotic pathway, the depolarization of the mitochondrial inner membrane, and a significant accumulation in cells. Frontiers Media S.A. 2022-07-13 /pmc/articles/PMC9325969/ /pubmed/35910727 http://dx.doi.org/10.3389/fchem.2022.924584 Text en Copyright © 2022 Luciani, Galassi, Wang, Marchini, Cogo, Di Paolo and Dalla Via. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Luciani, Lorenzo
Galassi, Rossana
Wang, Junbiao
Marchini, Cristina
Cogo, Alessia
Di Paolo, Maria Luisa
Dalla Via, Lisa
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title_full Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title_fullStr Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title_full_unstemmed Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title_short Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
title_sort coinage metal compounds with 4-methoxy-diphenylphosphane benzoate ligand inhibit female cancer cell growth
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325969/
https://www.ncbi.nlm.nih.gov/pubmed/35910727
http://dx.doi.org/10.3389/fchem.2022.924584
work_keys_str_mv AT lucianilorenzo coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT galassirossana coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT wangjunbiao coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT marchinicristina coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT cogoalessia coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT dipaolomarialuisa coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth
AT dallavialisa coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth